KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 77 filers reported holding KYMERA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,597,199 | -37.0% | 834,227 | +4.1% | 0.00% | -50.0% |
| Q2 2023 | $18,421,549 | -20.4% | 801,285 | +2.6% | 0.00% | -33.3% |
| Q1 2023 | $23,135,973 | +123980.1% | 780,829 | +4.5% | 0.00% | 0.0% |
| Q4 2022 | $18,646 | -99.9% | 747,071 | +6.5% | 0.00% | +50.0% |
| Q3 2022 | $15,265,000 | +14.7% | 701,222 | +3.8% | 0.00% | 0.0% |
| Q2 2022 | $13,307,000 | -49.6% | 675,847 | +8.3% | 0.00% | -33.3% |
| Q1 2022 | $26,397,000 | -32.9% | 623,770 | +0.6% | 0.00% | -40.0% |
| Q4 2021 | $39,366,000 | +11.7% | 620,042 | +3.4% | 0.01% | 0.0% |
| Q3 2021 | $35,236,000 | +112.7% | 599,870 | +75.6% | 0.01% | +150.0% |
| Q2 2021 | $16,564,000 | +128.4% | 341,542 | +83.0% | 0.00% | +100.0% |
| Q1 2021 | $7,253,000 | -39.0% | 186,658 | -2.7% | 0.00% | -50.0% |
| Q4 2020 | $11,899,000 | +917.9% | 191,921 | +430.3% | 0.00% | – |
| Q3 2020 | $1,169,000 | – | 36,194 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |